Cytokine and Endothelial Activation Patterns Related to Severe and Non‐Severe Respiratory Viral Infections
Journal of Medical Virology · 2026
DOI: 10.1002/jmv.70784 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2026. Verfasst von Roberto Ferrarese und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Technological Innovation, University of Insubria, Varese, Italy. Hauptthemen laut MEDLINE: Cytokines, Respiratory Tract Infections, Virus Diseases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NATIONAL RECOVERY AND RESILIENCE PLAN (NRRP) - MISSION 4 COMPONENT 2 INVESTMENT 1.1 - "Fund for the National Research Program and for Projects of National Inte….
Abstract (Originalsprache)
Respiratory viral infections (RVIs) are a major cause of global morbidity and mortality. Severe cases are driven by dysregulated inflammation, impaired interferon (IFN) responses, and thromboinflammation, yet the mechanisms underlying endothelial dysfunction remain poorly defined. We collected 234 leftover material samples from hospitalized patients with PCR‐confirmed RVIs. Patients were stratified by viral etiology, differential involvement of the respiratory tract, age and possible co‐infections. Cytokines (IL‐6, IL‐8, IL‐1β, TNF‐α), IFNs (α/β/γ), and endothelial markers (ICAM‐1, VCAM‐1) were quantified using microfluidic immunoassays. Routine coagulation parameters were measured in a subset of patients. Compared with controls, RVI patients exhibited significantly elevated systemic cytokines ( p < 0.001). IL‐6 and IL‐8 were higher in patients with lower respiratory tract involvement, particularly in influenza cases. Elderly patients displayed reduced IFN‐α/β responses but increased proinflammatory CRP levels. Infants and children had higher ICAM‐1 but lower CRP levels. Patients with viral–bacterial co‐infections showed amplified IFN‐γ/IL‐1β/ICAM‐1 response. Older adults demonstrated prolonged prothrombin times and reduced fibrinogen, indicating coagulopathy. Severe RVIs are characterized by a triad of impaired antiviral IFN responses, hyperinflammation, and endothelial activation, culminating in thromboinflammation. Age, viral type and co‐infections critically shape host responses, underscoring the need for biomarker‐guided, personalized therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine and Technological Innovation, University of Insubria, Varese, Italy.
- Department of Biomedical, Surgical and Dental Sciences, University of Milano, Milan, Italy.
- Ospedale di Circolo e Fondazione Macchi, Laboratory of Medical Microbiology and Virology, Varese, Italy.
- Department of Pharmacological and Biomolecular Sciences, University of Milano, Milan, Italy.
ORCID-Profile: Maria Dolci, Federica Novazzi
Förderung
- NATIONAL RECOVERY AND RESILIENCE PLAN (NRRP) - MISSION 4 COMPONENT 2 INVESTMENT 1.1 - "Fund for the National Research Program and for Projects of National Inte…
Zitieren
APA
Ferrarese, R., Boutahar, S., Genoni, A. P., Arcari, G., Zambon, G., Dolci, M., Perego, F., D'alessandro, S., Delbue, S., Mancini, N., Signorini, L., & Novazzi, F. (2026). Cytokine and Endothelial Activation Patterns Related to Severe and Non‐Severe Respiratory Viral Infections. Journal of Medical Virology. https://doi.org/10.1002/jmv.70784
Vancouver
Ferrarese R, Boutahar S, Genoni AP, Arcari G, Zambon G, Dolci M, et al. Cytokine and Endothelial Activation Patterns Related to Severe and Non‐Severe Respiratory Viral Infections. Journal of Medical Virology. 2026. doi:10.1002/jmv.70784
BibTeX
@article{Ferrarese2026,
author = {Ferrarese, Roberto and Boutahar, Sara and Genoni, Angelo Paolo and Arcari, Gabriele and Zambon, Gaia and Dolci, Maria and Perego, Federica and D'alessandro, Sara and Delbue, Serena and Mancini, Nicasio and Signorini, Lucia and Novazzi, Federica},
title = {Cytokine and Endothelial Activation Patterns Related to Severe and Non‐Severe Respiratory Viral Infections},
journal = {Journal of Medical Virology},
year = {2026},
doi = {10.1002/jmv.70784}
}
EUVIMED